nodes	percent_of_prediction	percent_of_DWPC	metapath
Liotrix—ALB—chronic obstructive pulmonary disease	0.359	1	CbGaD
Liotrix—SLCO1A2—Prednisolone—chronic obstructive pulmonary disease	0.0845	0.275	CbGbCtD
Liotrix—SLCO1A2—Prednisone—chronic obstructive pulmonary disease	0.0798	0.26	CbGbCtD
Liotrix—CYP2C8—Montelukast—chronic obstructive pulmonary disease	0.0575	0.187	CbGbCtD
Liotrix—ALB—Prednisone—chronic obstructive pulmonary disease	0.0412	0.134	CbGbCtD
Liotrix—ABCB1—Prednisolone—chronic obstructive pulmonary disease	0.0228	0.0743	CbGbCtD
Liotrix—ABCB1—Prednisone—chronic obstructive pulmonary disease	0.0216	0.0701	CbGbCtD
Liotrix—THRA—connective tissue—chronic obstructive pulmonary disease	0.00131	0.0971	CbGeAlD
Liotrix—SLCO4C1—trachea—chronic obstructive pulmonary disease	0.00115	0.085	CbGeAlD
Liotrix—TTR—respiratory system—chronic obstructive pulmonary disease	0.00111	0.082	CbGeAlD
Liotrix—SLC16A2—trachea—chronic obstructive pulmonary disease	0.000995	0.0738	CbGeAlD
Liotrix—TTR—connective tissue—chronic obstructive pulmonary disease	0.000973	0.0722	CbGeAlD
Liotrix—Levothyroxine—ALB—chronic obstructive pulmonary disease	0.00092	0.584	CrCbGaD
Liotrix—SLCO4C1—lung—chronic obstructive pulmonary disease	0.000823	0.0611	CbGeAlD
Liotrix—SLCO4A1—bronchus—chronic obstructive pulmonary disease	0.000815	0.0605	CbGeAlD
Liotrix—SLCO1B3—lung—chronic obstructive pulmonary disease	0.0008	0.0594	CbGeAlD
Liotrix—THRA—lung—chronic obstructive pulmonary disease	0.000789	0.0586	CbGeAlD
Liotrix—THRB—lung—chronic obstructive pulmonary disease	0.000789	0.0586	CbGeAlD
Liotrix—SLCO4A1—trachea—chronic obstructive pulmonary disease	0.000732	0.0543	CbGeAlD
Liotrix—SLC16A2—lung—chronic obstructive pulmonary disease	0.000715	0.0531	CbGeAlD
Liotrix—Liothyronine—ALB—chronic obstructive pulmonary disease	0.000655	0.416	CrCbGaD
Liotrix—TTR—lung—chronic obstructive pulmonary disease	0.000587	0.0435	CbGeAlD
Liotrix—SLCO4A1—lung—chronic obstructive pulmonary disease	0.000526	0.039	CbGeAlD
Liotrix—Tension—Salbutamol—chronic obstructive pulmonary disease	0.00048	0.00186	CcSEcCtD
Liotrix—Dysgeusia—Salbutamol—chronic obstructive pulmonary disease	0.000479	0.00185	CcSEcCtD
Liotrix—Musculoskeletal discomfort—Tiotropium—chronic obstructive pulmonary disease	0.000477	0.00185	CcSEcCtD
Liotrix—Agitation—Arformoterol—chronic obstructive pulmonary disease	0.000476	0.00184	CcSEcCtD
Liotrix—Agitation—Formoterol—chronic obstructive pulmonary disease	0.000476	0.00184	CcSEcCtD
Liotrix—Tremor—Montelukast—chronic obstructive pulmonary disease	0.000475	0.00184	CcSEcCtD
Liotrix—Nervousness—Salbutamol—chronic obstructive pulmonary disease	0.000475	0.00184	CcSEcCtD
Liotrix—Insomnia—Tiotropium—chronic obstructive pulmonary disease	0.000473	0.00183	CcSEcCtD
Liotrix—Angioedema—Formoterol—chronic obstructive pulmonary disease	0.000473	0.00183	CcSEcCtD
Liotrix—Angioedema—Arformoterol—chronic obstructive pulmonary disease	0.000473	0.00183	CcSEcCtD
Liotrix—Paraesthesia—Tiotropium—chronic obstructive pulmonary disease	0.00047	0.00182	CcSEcCtD
Liotrix—Agitation—Montelukast—chronic obstructive pulmonary disease	0.000466	0.0018	CcSEcCtD
Liotrix—Angioedema—Montelukast—chronic obstructive pulmonary disease	0.000463	0.00179	CcSEcCtD
Liotrix—SLC16A10—lung—chronic obstructive pulmonary disease	0.000461	0.0342	CbGeAlD
Liotrix—Affect lability—Prednisolone—chronic obstructive pulmonary disease	0.000458	0.00177	CcSEcCtD
Liotrix—Tremor—Salbutamol—chronic obstructive pulmonary disease	0.000458	0.00177	CcSEcCtD
Liotrix—Palpitations—Formoterol—chronic obstructive pulmonary disease	0.000457	0.00177	CcSEcCtD
Liotrix—Palpitations—Arformoterol—chronic obstructive pulmonary disease	0.000457	0.00177	CcSEcCtD
Liotrix—Gastrointestinal pain—Aminophylline—chronic obstructive pulmonary disease	0.000454	0.00176	CcSEcCtD
Liotrix—Agitation—Salbutamol—chronic obstructive pulmonary disease	0.000449	0.00174	CcSEcCtD
Liotrix—Palpitations—Montelukast—chronic obstructive pulmonary disease	0.000448	0.00173	CcSEcCtD
Liotrix—Constipation—Tiotropium—chronic obstructive pulmonary disease	0.000448	0.00173	CcSEcCtD
Liotrix—Hypertension—Formoterol—chronic obstructive pulmonary disease	0.000447	0.00173	CcSEcCtD
Liotrix—Hypertension—Arformoterol—chronic obstructive pulmonary disease	0.000447	0.00173	CcSEcCtD
Liotrix—Angioedema—Salbutamol—chronic obstructive pulmonary disease	0.000447	0.00173	CcSEcCtD
Liotrix—Cardiac arrest—Prednisolone—chronic obstructive pulmonary disease	0.000443	0.00171	CcSEcCtD
Liotrix—Fluid retention—Prednisone—chronic obstructive pulmonary disease	0.000442	0.00171	CcSEcCtD
Liotrix—Mood swings—Prednisolone—chronic obstructive pulmonary disease	0.000441	0.00171	CcSEcCtD
Liotrix—Urticaria—Aminophylline—chronic obstructive pulmonary disease	0.000441	0.00171	CcSEcCtD
Liotrix—Chest pain—Formoterol—chronic obstructive pulmonary disease	0.000441	0.00171	CcSEcCtD
Liotrix—Arthralgia—Formoterol—chronic obstructive pulmonary disease	0.000441	0.00171	CcSEcCtD
Liotrix—Arthralgia—Arformoterol—chronic obstructive pulmonary disease	0.000441	0.00171	CcSEcCtD
Liotrix—Chest pain—Arformoterol—chronic obstructive pulmonary disease	0.000441	0.00171	CcSEcCtD
Liotrix—Convulsion—Montelukast—chronic obstructive pulmonary disease	0.000439	0.0017	CcSEcCtD
Liotrix—Anxiety—Arformoterol—chronic obstructive pulmonary disease	0.000439	0.0017	CcSEcCtD
Liotrix—Anxiety—Formoterol—chronic obstructive pulmonary disease	0.000439	0.0017	CcSEcCtD
Liotrix—Abdominal pain—Aminophylline—chronic obstructive pulmonary disease	0.000439	0.0017	CcSEcCtD
Liotrix—Body temperature increased—Aminophylline—chronic obstructive pulmonary disease	0.000439	0.0017	CcSEcCtD
Liotrix—Syncope—Salbutamol—chronic obstructive pulmonary disease	0.000438	0.0017	CcSEcCtD
Liotrix—Palpitations—Salbutamol—chronic obstructive pulmonary disease	0.000432	0.00167	CcSEcCtD
Liotrix—Arthralgia—Montelukast—chronic obstructive pulmonary disease	0.000432	0.00167	CcSEcCtD
Liotrix—Anxiety—Montelukast—chronic obstructive pulmonary disease	0.00043	0.00167	CcSEcCtD
Liotrix—Loss of consciousness—Salbutamol—chronic obstructive pulmonary disease	0.00043	0.00166	CcSEcCtD
Liotrix—Gastrointestinal pain—Tiotropium—chronic obstructive pulmonary disease	0.000428	0.00166	CcSEcCtD
Liotrix—Oedema—Formoterol—chronic obstructive pulmonary disease	0.000422	0.00164	CcSEcCtD
Liotrix—Anaphylactic shock—Arformoterol—chronic obstructive pulmonary disease	0.000422	0.00164	CcSEcCtD
Liotrix—Anaphylactic shock—Formoterol—chronic obstructive pulmonary disease	0.000422	0.00164	CcSEcCtD
Liotrix—Oedema—Arformoterol—chronic obstructive pulmonary disease	0.000422	0.00164	CcSEcCtD
Liotrix—Hypertension—Salbutamol—chronic obstructive pulmonary disease	0.000422	0.00163	CcSEcCtD
Liotrix—Infection—Arformoterol—chronic obstructive pulmonary disease	0.00042	0.00162	CcSEcCtD
Liotrix—Infection—Formoterol—chronic obstructive pulmonary disease	0.00042	0.00162	CcSEcCtD
Liotrix—Arthralgia—Salbutamol—chronic obstructive pulmonary disease	0.000416	0.00161	CcSEcCtD
Liotrix—Chest pain—Salbutamol—chronic obstructive pulmonary disease	0.000416	0.00161	CcSEcCtD
Liotrix—Urticaria—Tiotropium—chronic obstructive pulmonary disease	0.000416	0.00161	CcSEcCtD
Liotrix—Anxiety—Salbutamol—chronic obstructive pulmonary disease	0.000415	0.00161	CcSEcCtD
Liotrix—Abdominal pain—Tiotropium—chronic obstructive pulmonary disease	0.000414	0.0016	CcSEcCtD
Liotrix—Anaphylactic shock—Montelukast—chronic obstructive pulmonary disease	0.000414	0.0016	CcSEcCtD
Liotrix—Oedema—Montelukast—chronic obstructive pulmonary disease	0.000414	0.0016	CcSEcCtD
Liotrix—Tachycardia—Formoterol—chronic obstructive pulmonary disease	0.000412	0.0016	CcSEcCtD
Liotrix—Tachycardia—Arformoterol—chronic obstructive pulmonary disease	0.000412	0.0016	CcSEcCtD
Liotrix—Infection—Montelukast—chronic obstructive pulmonary disease	0.000411	0.00159	CcSEcCtD
Liotrix—Muscular weakness—Prednisolone—chronic obstructive pulmonary disease	0.000411	0.00159	CcSEcCtD
Liotrix—Hypersensitivity—Aminophylline—chronic obstructive pulmonary disease	0.000409	0.00158	CcSEcCtD
Liotrix—Hyperkinesia—Prednisone—chronic obstructive pulmonary disease	0.000406	0.00157	CcSEcCtD
Liotrix—Abdominal distension—Prednisolone—chronic obstructive pulmonary disease	0.000405	0.00157	CcSEcCtD
Liotrix—Sepsis—Prednisone—chronic obstructive pulmonary disease	0.000404	0.00157	CcSEcCtD
Liotrix—Anaphylactic shock—Salbutamol—chronic obstructive pulmonary disease	0.000399	0.00154	CcSEcCtD
Liotrix—Oedema—Salbutamol—chronic obstructive pulmonary disease	0.000399	0.00154	CcSEcCtD
Liotrix—Infection—Salbutamol—chronic obstructive pulmonary disease	0.000396	0.00153	CcSEcCtD
Liotrix—Hypotension—Formoterol—chronic obstructive pulmonary disease	0.000395	0.00153	CcSEcCtD
Liotrix—Hypotension—Arformoterol—chronic obstructive pulmonary disease	0.000395	0.00153	CcSEcCtD
Liotrix—Pruritus—Aminophylline—chronic obstructive pulmonary disease	0.000393	0.00152	CcSEcCtD
Liotrix—Shock—Salbutamol—chronic obstructive pulmonary disease	0.000392	0.00152	CcSEcCtD
Liotrix—Sweating increased—Prednisolone—chronic obstructive pulmonary disease	0.000392	0.00152	CcSEcCtD
Liotrix—Tachycardia—Salbutamol—chronic obstructive pulmonary disease	0.000389	0.00151	CcSEcCtD
Liotrix—Hypersensitivity—Tiotropium—chronic obstructive pulmonary disease	0.000386	0.00149	CcSEcCtD
Liotrix—Hyperhidrosis—Salbutamol—chronic obstructive pulmonary disease	0.000386	0.00149	CcSEcCtD
Liotrix—Musculoskeletal discomfort—Formoterol—chronic obstructive pulmonary disease	0.000385	0.00149	CcSEcCtD
Liotrix—Musculoskeletal discomfort—Arformoterol—chronic obstructive pulmonary disease	0.000385	0.00149	CcSEcCtD
Liotrix—Insomnia—Arformoterol—chronic obstructive pulmonary disease	0.000382	0.00148	CcSEcCtD
Liotrix—Insomnia—Formoterol—chronic obstructive pulmonary disease	0.000382	0.00148	CcSEcCtD
Liotrix—Anorexia—Salbutamol—chronic obstructive pulmonary disease	0.00038	0.00147	CcSEcCtD
Liotrix—Diarrhoea—Aminophylline—chronic obstructive pulmonary disease	0.00038	0.00147	CcSEcCtD
Liotrix—Musculoskeletal discomfort—Montelukast—chronic obstructive pulmonary disease	0.000377	0.00146	CcSEcCtD
Liotrix—SLCO1A2—lung—chronic obstructive pulmonary disease	0.000377	0.0279	CbGeAlD
Liotrix—Dyspnoea—Formoterol—chronic obstructive pulmonary disease	0.000377	0.00146	CcSEcCtD
Liotrix—Dyspnoea—Arformoterol—chronic obstructive pulmonary disease	0.000377	0.00146	CcSEcCtD
Liotrix—Insomnia—Montelukast—chronic obstructive pulmonary disease	0.000374	0.00145	CcSEcCtD
Liotrix—Cardiac failure congestive—Prednisone—chronic obstructive pulmonary disease	0.000373	0.00144	CcSEcCtD
Liotrix—Hypotension—Salbutamol—chronic obstructive pulmonary disease	0.000373	0.00144	CcSEcCtD
Liotrix—Paraesthesia—Montelukast—chronic obstructive pulmonary disease	0.000372	0.00144	CcSEcCtD
Liotrix—Pruritus—Tiotropium—chronic obstructive pulmonary disease	0.00037	0.00143	CcSEcCtD
Liotrix—Dizziness—Aminophylline—chronic obstructive pulmonary disease	0.000367	0.00142	CcSEcCtD
Liotrix—Fatigue—Formoterol—chronic obstructive pulmonary disease	0.000364	0.00141	CcSEcCtD
Liotrix—Fatigue—Arformoterol—chronic obstructive pulmonary disease	0.000364	0.00141	CcSEcCtD
Liotrix—Musculoskeletal discomfort—Salbutamol—chronic obstructive pulmonary disease	0.000363	0.00141	CcSEcCtD
Liotrix—Constipation—Formoterol—chronic obstructive pulmonary disease	0.000361	0.0014	CcSEcCtD
Liotrix—Constipation—Arformoterol—chronic obstructive pulmonary disease	0.000361	0.0014	CcSEcCtD
Liotrix—Insomnia—Salbutamol—chronic obstructive pulmonary disease	0.000361	0.0014	CcSEcCtD
Liotrix—Increased appetite—Prednisone—chronic obstructive pulmonary disease	0.00036	0.00139	CcSEcCtD
Liotrix—Paraesthesia—Salbutamol—chronic obstructive pulmonary disease	0.000358	0.00139	CcSEcCtD
Liotrix—Fatigue—Montelukast—chronic obstructive pulmonary disease	0.000357	0.00138	CcSEcCtD
Liotrix—Dyspnoea—Salbutamol—chronic obstructive pulmonary disease	0.000356	0.00138	CcSEcCtD
Liotrix—Acute coronary syndrome—Prednisolone—chronic obstructive pulmonary disease	0.000354	0.00137	CcSEcCtD
Liotrix—Vomiting—Aminophylline—chronic obstructive pulmonary disease	0.000353	0.00137	CcSEcCtD
Liotrix—Myocardial infarction—Prednisolone—chronic obstructive pulmonary disease	0.000352	0.00136	CcSEcCtD
Liotrix—Rash—Aminophylline—chronic obstructive pulmonary disease	0.00035	0.00135	CcSEcCtD
Liotrix—Dermatitis—Aminophylline—chronic obstructive pulmonary disease	0.00035	0.00135	CcSEcCtD
Liotrix—Feeling abnormal—Arformoterol—chronic obstructive pulmonary disease	0.000348	0.00135	CcSEcCtD
Liotrix—Feeling abnormal—Formoterol—chronic obstructive pulmonary disease	0.000348	0.00135	CcSEcCtD
Liotrix—Headache—Aminophylline—chronic obstructive pulmonary disease	0.000348	0.00135	CcSEcCtD
Liotrix—Decreased appetite—Salbutamol—chronic obstructive pulmonary disease	0.000347	0.00134	CcSEcCtD
Liotrix—Cardiac failure—Prednisone—chronic obstructive pulmonary disease	0.000347	0.00134	CcSEcCtD
Liotrix—Dizziness—Tiotropium—chronic obstructive pulmonary disease	0.000346	0.00134	CcSEcCtD
Liotrix—Gastrointestinal pain—Formoterol—chronic obstructive pulmonary disease	0.000345	0.00134	CcSEcCtD
Liotrix—Gastrointestinal pain—Arformoterol—chronic obstructive pulmonary disease	0.000345	0.00134	CcSEcCtD
Liotrix—Fatigue—Salbutamol—chronic obstructive pulmonary disease	0.000344	0.00133	CcSEcCtD
Liotrix—Constipation—Salbutamol—chronic obstructive pulmonary disease	0.000341	0.00132	CcSEcCtD
Liotrix—Gastrointestinal pain—Montelukast—chronic obstructive pulmonary disease	0.000338	0.00131	CcSEcCtD
Liotrix—Urticaria—Formoterol—chronic obstructive pulmonary disease	0.000336	0.0013	CcSEcCtD
Liotrix—Urticaria—Arformoterol—chronic obstructive pulmonary disease	0.000336	0.0013	CcSEcCtD
Liotrix—Abdominal pain—Arformoterol—chronic obstructive pulmonary disease	0.000334	0.00129	CcSEcCtD
Liotrix—Body temperature increased—Arformoterol—chronic obstructive pulmonary disease	0.000334	0.00129	CcSEcCtD
Liotrix—Abdominal pain—Formoterol—chronic obstructive pulmonary disease	0.000334	0.00129	CcSEcCtD
Liotrix—Body temperature increased—Formoterol—chronic obstructive pulmonary disease	0.000334	0.00129	CcSEcCtD
Liotrix—Affect lability—Prednisone—chronic obstructive pulmonary disease	0.000333	0.00129	CcSEcCtD
Liotrix—Vomiting—Tiotropium—chronic obstructive pulmonary disease	0.000333	0.00129	CcSEcCtD
Liotrix—Rash—Tiotropium—chronic obstructive pulmonary disease	0.00033	0.00128	CcSEcCtD
Liotrix—Dermatitis—Tiotropium—chronic obstructive pulmonary disease	0.00033	0.00128	CcSEcCtD
Liotrix—Nausea—Aminophylline—chronic obstructive pulmonary disease	0.00033	0.00128	CcSEcCtD
Liotrix—Urticaria—Montelukast—chronic obstructive pulmonary disease	0.000329	0.00127	CcSEcCtD
Liotrix—Feeling abnormal—Salbutamol—chronic obstructive pulmonary disease	0.000329	0.00127	CcSEcCtD
Liotrix—Headache—Tiotropium—chronic obstructive pulmonary disease	0.000328	0.00127	CcSEcCtD
Liotrix—Abdominal pain—Montelukast—chronic obstructive pulmonary disease	0.000327	0.00127	CcSEcCtD
Liotrix—Body temperature increased—Montelukast—chronic obstructive pulmonary disease	0.000327	0.00127	CcSEcCtD
Liotrix—Gastrointestinal pain—Salbutamol—chronic obstructive pulmonary disease	0.000326	0.00126	CcSEcCtD
Liotrix—Irritability—Prednisone—chronic obstructive pulmonary disease	0.000323	0.00125	CcSEcCtD
Liotrix—Cardiac arrest—Prednisone—chronic obstructive pulmonary disease	0.000322	0.00125	CcSEcCtD
Liotrix—Mood swings—Prednisone—chronic obstructive pulmonary disease	0.00032	0.00124	CcSEcCtD
Liotrix—Urticaria—Salbutamol—chronic obstructive pulmonary disease	0.000317	0.00123	CcSEcCtD
Liotrix—Abdominal pain—Salbutamol—chronic obstructive pulmonary disease	0.000315	0.00122	CcSEcCtD
Liotrix—Body temperature increased—Salbutamol—chronic obstructive pulmonary disease	0.000315	0.00122	CcSEcCtD
Liotrix—Hypersensitivity—Arformoterol—chronic obstructive pulmonary disease	0.000311	0.0012	CcSEcCtD
Liotrix—Hypersensitivity—Formoterol—chronic obstructive pulmonary disease	0.000311	0.0012	CcSEcCtD
Liotrix—Nausea—Tiotropium—chronic obstructive pulmonary disease	0.000311	0.0012	CcSEcCtD
Liotrix—Hypokalaemia—Prednisone—chronic obstructive pulmonary disease	0.000308	0.00119	CcSEcCtD
Liotrix—Hypersensitivity—Montelukast—chronic obstructive pulmonary disease	0.000305	0.00118	CcSEcCtD
Liotrix—Asthenia—Formoterol—chronic obstructive pulmonary disease	0.000303	0.00117	CcSEcCtD
Liotrix—Asthenia—Arformoterol—chronic obstructive pulmonary disease	0.000303	0.00117	CcSEcCtD
Liotrix—Pruritus—Formoterol—chronic obstructive pulmonary disease	0.000299	0.00116	CcSEcCtD
Liotrix—Pruritus—Arformoterol—chronic obstructive pulmonary disease	0.000299	0.00116	CcSEcCtD
Liotrix—Muscular weakness—Prednisone—chronic obstructive pulmonary disease	0.000298	0.00115	CcSEcCtD
Liotrix—Asthenia—Montelukast—chronic obstructive pulmonary disease	0.000297	0.00115	CcSEcCtD
Liotrix—Abdominal distension—Prednisone—chronic obstructive pulmonary disease	0.000294	0.00114	CcSEcCtD
Liotrix—Hypersensitivity—Salbutamol—chronic obstructive pulmonary disease	0.000294	0.00114	CcSEcCtD
Liotrix—Pruritus—Montelukast—chronic obstructive pulmonary disease	0.000293	0.00113	CcSEcCtD
Liotrix—Diarrhoea—Formoterol—chronic obstructive pulmonary disease	0.000289	0.00112	CcSEcCtD
Liotrix—Diarrhoea—Arformoterol—chronic obstructive pulmonary disease	0.000289	0.00112	CcSEcCtD
Liotrix—Arrhythmia—Prednisolone—chronic obstructive pulmonary disease	0.000288	0.00111	CcSEcCtD
Liotrix—Asthenia—Salbutamol—chronic obstructive pulmonary disease	0.000286	0.00111	CcSEcCtD
Liotrix—Sweating increased—Prednisone—chronic obstructive pulmonary disease	0.000285	0.0011	CcSEcCtD
Liotrix—Diarrhoea—Montelukast—chronic obstructive pulmonary disease	0.000283	0.0011	CcSEcCtD
Liotrix—Pruritus—Salbutamol—chronic obstructive pulmonary disease	0.000282	0.00109	CcSEcCtD
Liotrix—Dizziness—Arformoterol—chronic obstructive pulmonary disease	0.000279	0.00108	CcSEcCtD
Liotrix—Dizziness—Formoterol—chronic obstructive pulmonary disease	0.000279	0.00108	CcSEcCtD
Liotrix—Dizziness—Montelukast—chronic obstructive pulmonary disease	0.000274	0.00106	CcSEcCtD
Liotrix—Diarrhoea—Salbutamol—chronic obstructive pulmonary disease	0.000273	0.00106	CcSEcCtD
Liotrix—Vomiting—Formoterol—chronic obstructive pulmonary disease	0.000269	0.00104	CcSEcCtD
Liotrix—Vomiting—Arformoterol—chronic obstructive pulmonary disease	0.000269	0.00104	CcSEcCtD
Liotrix—Rash—Arformoterol—chronic obstructive pulmonary disease	0.000266	0.00103	CcSEcCtD
Liotrix—Rash—Formoterol—chronic obstructive pulmonary disease	0.000266	0.00103	CcSEcCtD
Liotrix—Dermatitis—Arformoterol—chronic obstructive pulmonary disease	0.000266	0.00103	CcSEcCtD
Liotrix—Dermatitis—Formoterol—chronic obstructive pulmonary disease	0.000266	0.00103	CcSEcCtD
Liotrix—Headache—Arformoterol—chronic obstructive pulmonary disease	0.000265	0.00102	CcSEcCtD
Liotrix—Headache—Formoterol—chronic obstructive pulmonary disease	0.000265	0.00102	CcSEcCtD
Liotrix—Weight decreased—Prednisone—chronic obstructive pulmonary disease	0.000265	0.00102	CcSEcCtD
Liotrix—Vision blurred—Prednisolone—chronic obstructive pulmonary disease	0.000264	0.00102	CcSEcCtD
Liotrix—Dizziness—Salbutamol—chronic obstructive pulmonary disease	0.000264	0.00102	CcSEcCtD
Liotrix—Vomiting—Montelukast—chronic obstructive pulmonary disease	0.000263	0.00102	CcSEcCtD
Liotrix—Rash—Montelukast—chronic obstructive pulmonary disease	0.000261	0.00101	CcSEcCtD
Liotrix—Dermatitis—Montelukast—chronic obstructive pulmonary disease	0.000261	0.00101	CcSEcCtD
Liotrix—Headache—Montelukast—chronic obstructive pulmonary disease	0.000259	0.001	CcSEcCtD
Liotrix—Acute coronary syndrome—Prednisone—chronic obstructive pulmonary disease	0.000257	0.000995	CcSEcCtD
Liotrix—Angioedema—Prednisolone—chronic obstructive pulmonary disease	0.000256	0.000992	CcSEcCtD
Liotrix—Myocardial infarction—Prednisone—chronic obstructive pulmonary disease	0.000256	0.000989	CcSEcCtD
Liotrix—Vomiting—Salbutamol—chronic obstructive pulmonary disease	0.000254	0.000982	CcSEcCtD
Liotrix—Rash—Salbutamol—chronic obstructive pulmonary disease	0.000252	0.000974	CcSEcCtD
Liotrix—Syncope—Prednisolone—chronic obstructive pulmonary disease	0.000251	0.000973	CcSEcCtD
Liotrix—Dermatitis—Salbutamol—chronic obstructive pulmonary disease	0.000251	0.000973	CcSEcCtD
Liotrix—Nausea—Formoterol—chronic obstructive pulmonary disease	0.000251	0.000971	CcSEcCtD
Liotrix—Nausea—Arformoterol—chronic obstructive pulmonary disease	0.000251	0.000971	CcSEcCtD
Liotrix—Headache—Salbutamol—chronic obstructive pulmonary disease	0.00025	0.000967	CcSEcCtD
Liotrix—Loss of consciousness—Prednisolone—chronic obstructive pulmonary disease	0.000246	0.000954	CcSEcCtD
Liotrix—Nausea—Montelukast—chronic obstructive pulmonary disease	0.000246	0.000951	CcSEcCtD
Liotrix—Convulsion—Prednisolone—chronic obstructive pulmonary disease	0.000243	0.00094	CcSEcCtD
Liotrix—Hypertension—Prednisolone—chronic obstructive pulmonary disease	0.000242	0.000937	CcSEcCtD
Liotrix—ABCB1—respiratory system—chronic obstructive pulmonary disease	0.000238	0.0176	CbGeAlD
Liotrix—Nausea—Salbutamol—chronic obstructive pulmonary disease	0.000237	0.000917	CcSEcCtD
Liotrix—Anaphylactic shock—Prednisolone—chronic obstructive pulmonary disease	0.000229	0.000886	CcSEcCtD
Liotrix—Oedema—Prednisolone—chronic obstructive pulmonary disease	0.000229	0.000886	CcSEcCtD
Liotrix—Shock—Prednisolone—chronic obstructive pulmonary disease	0.000225	0.000871	CcSEcCtD
Liotrix—Tachycardia—Prednisolone—chronic obstructive pulmonary disease	0.000223	0.000864	CcSEcCtD
Liotrix—Hyperhidrosis—Prednisolone—chronic obstructive pulmonary disease	0.000221	0.000856	CcSEcCtD
Liotrix—Flushing—Prednisone—chronic obstructive pulmonary disease	0.000217	0.000841	CcSEcCtD
Liotrix—Arrhythmia—Prednisone—chronic obstructive pulmonary disease	0.000209	0.000809	CcSEcCtD
Liotrix—Insomnia—Prednisolone—chronic obstructive pulmonary disease	0.000207	0.000801	CcSEcCtD
Liotrix—Alopecia—Prednisone—chronic obstructive pulmonary disease	0.000207	0.000801	CcSEcCtD
Liotrix—Paraesthesia—Prednisolone—chronic obstructive pulmonary disease	0.000205	0.000795	CcSEcCtD
Liotrix—Vision blurred—Prednisone—chronic obstructive pulmonary disease	0.000192	0.000743	CcSEcCtD
Liotrix—Feeling abnormal—Prednisolone—chronic obstructive pulmonary disease	0.000189	0.00073	CcSEcCtD
Liotrix—Agitation—Prednisone—chronic obstructive pulmonary disease	0.000187	0.000725	CcSEcCtD
Liotrix—Angioedema—Prednisone—chronic obstructive pulmonary disease	0.000186	0.000721	CcSEcCtD
Liotrix—Syncope—Prednisone—chronic obstructive pulmonary disease	0.000183	0.000707	CcSEcCtD
Liotrix—Urticaria—Prednisolone—chronic obstructive pulmonary disease	0.000182	0.000704	CcSEcCtD
Liotrix—Loss of consciousness—Prednisone—chronic obstructive pulmonary disease	0.000179	0.000693	CcSEcCtD
Liotrix—Convulsion—Prednisone—chronic obstructive pulmonary disease	0.000177	0.000683	CcSEcCtD
Liotrix—Hypertension—Prednisone—chronic obstructive pulmonary disease	0.000176	0.000681	CcSEcCtD
Liotrix—ABCB1—trachea—chronic obstructive pulmonary disease	0.000176	0.013	CbGeAlD
Liotrix—Arthralgia—Prednisone—chronic obstructive pulmonary disease	0.000173	0.000671	CcSEcCtD
Liotrix—Anxiety—Prednisone—chronic obstructive pulmonary disease	0.000173	0.000669	CcSEcCtD
Liotrix—Hypersensitivity—Prednisolone—chronic obstructive pulmonary disease	0.000169	0.000653	CcSEcCtD
Liotrix—Oedema—Prednisone—chronic obstructive pulmonary disease	0.000166	0.000644	CcSEcCtD
Liotrix—Anaphylactic shock—Prednisone—chronic obstructive pulmonary disease	0.000166	0.000644	CcSEcCtD
Liotrix—Infection—Prednisone—chronic obstructive pulmonary disease	0.000165	0.000639	CcSEcCtD
Liotrix—Shock—Prednisone—chronic obstructive pulmonary disease	0.000164	0.000633	CcSEcCtD
Liotrix—Tachycardia—Prednisone—chronic obstructive pulmonary disease	0.000162	0.000628	CcSEcCtD
Liotrix—Hyperhidrosis—Prednisone—chronic obstructive pulmonary disease	0.000161	0.000622	CcSEcCtD
Liotrix—Anorexia—Prednisone—chronic obstructive pulmonary disease	0.000158	0.000613	CcSEcCtD
Liotrix—Musculoskeletal discomfort—Prednisone—chronic obstructive pulmonary disease	0.000151	0.000586	CcSEcCtD
Liotrix—Dizziness—Prednisolone—chronic obstructive pulmonary disease	0.000151	0.000586	CcSEcCtD
Liotrix—Insomnia—Prednisone—chronic obstructive pulmonary disease	0.00015	0.000582	CcSEcCtD
Liotrix—Paraesthesia—Prednisone—chronic obstructive pulmonary disease	0.000149	0.000578	CcSEcCtD
Liotrix—Decreased appetite—Prednisone—chronic obstructive pulmonary disease	0.000145	0.000559	CcSEcCtD
Liotrix—Rash—Prednisolone—chronic obstructive pulmonary disease	0.000144	0.000558	CcSEcCtD
Liotrix—Dermatitis—Prednisolone—chronic obstructive pulmonary disease	0.000144	0.000558	CcSEcCtD
Liotrix—Fatigue—Prednisone—chronic obstructive pulmonary disease	0.000143	0.000555	CcSEcCtD
Liotrix—Headache—Prednisolone—chronic obstructive pulmonary disease	0.000143	0.000555	CcSEcCtD
Liotrix—Constipation—Prednisone—chronic obstructive pulmonary disease	0.000142	0.00055	CcSEcCtD
Liotrix—Feeling abnormal—Prednisone—chronic obstructive pulmonary disease	0.000137	0.00053	CcSEcCtD
Liotrix—Gastrointestinal pain—Prednisone—chronic obstructive pulmonary disease	0.000136	0.000526	CcSEcCtD
Liotrix—Nausea—Prednisolone—chronic obstructive pulmonary disease	0.000136	0.000526	CcSEcCtD
Liotrix—Urticaria—Prednisone—chronic obstructive pulmonary disease	0.000132	0.000511	CcSEcCtD
Liotrix—Body temperature increased—Prednisone—chronic obstructive pulmonary disease	0.000131	0.000509	CcSEcCtD
Liotrix—Abdominal pain—Prednisone—chronic obstructive pulmonary disease	0.000131	0.000509	CcSEcCtD
Liotrix—SLCO1B3—Metabolism—APIP—chronic obstructive pulmonary disease	0.000126	0.00212	CbGpPWpGaD
Liotrix—ABCB1—lung—chronic obstructive pulmonary disease	0.000126	0.00936	CbGeAlD
Liotrix—THRB—SIDS Susceptibility Pathways—IL6—chronic obstructive pulmonary disease	0.000125	0.00209	CbGpPWpGaD
Liotrix—SLCO1B1—Metabolism of lipids and lipoproteins—GC—chronic obstructive pulmonary disease	0.000123	0.00206	CbGpPWpGaD
Liotrix—TTR—Extracellular matrix organization—SERPINE1—chronic obstructive pulmonary disease	0.000123	0.00205	CbGpPWpGaD
Liotrix—Hypersensitivity—Prednisone—chronic obstructive pulmonary disease	0.000122	0.000474	CcSEcCtD
Liotrix—ABCB1—HIF-1-alpha transcription factor network—EDN1—chronic obstructive pulmonary disease	0.000121	0.00203	CbGpPWpGaD
Liotrix—SLC10A1—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	0.000121	0.00202	CbGpPWpGaD
Liotrix—Asthenia—Prednisone—chronic obstructive pulmonary disease	0.000119	0.000462	CcSEcCtD
Liotrix—Pruritus—Prednisone—chronic obstructive pulmonary disease	0.000118	0.000455	CcSEcCtD
Liotrix—THRA—Gene Expression—CTGF—chronic obstructive pulmonary disease	0.000117	0.00196	CbGpPWpGaD
Liotrix—THRB—Gene Expression—CTGF—chronic obstructive pulmonary disease	0.000117	0.00196	CbGpPWpGaD
Liotrix—ALB—Folate Metabolism—CRP—chronic obstructive pulmonary disease	0.000115	0.00193	CbGpPWpGaD
Liotrix—SLCO1C1—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	0.000115	0.00192	CbGpPWpGaD
Liotrix—CYP2C8—Phase 1 - Functionalization of compounds—CYP1A1—chronic obstructive pulmonary disease	0.000114	0.00191	CbGpPWpGaD
Liotrix—Diarrhoea—Prednisone—chronic obstructive pulmonary disease	0.000114	0.00044	CcSEcCtD
Liotrix—ALB—Transmembrane transport of small molecules—TRPV4—chronic obstructive pulmonary disease	0.000113	0.0019	CbGpPWpGaD
Liotrix—TTR—Signaling Pathways—RAPGEF3—chronic obstructive pulmonary disease	0.000113	0.00189	CbGpPWpGaD
Liotrix—ABCB1—Transmembrane transport of small molecules—ATP2C2—chronic obstructive pulmonary disease	0.000111	0.00186	CbGpPWpGaD
Liotrix—THRB—Generic Transcription Pathway—SERPINE1—chronic obstructive pulmonary disease	0.000111	0.00185	CbGpPWpGaD
Liotrix—THRA—Generic Transcription Pathway—SERPINE1—chronic obstructive pulmonary disease	0.000111	0.00185	CbGpPWpGaD
Liotrix—Dizziness—Prednisone—chronic obstructive pulmonary disease	0.00011	0.000426	CcSEcCtD
Liotrix—THRB—Gene Expression—HDAC2—chronic obstructive pulmonary disease	0.000109	0.00182	CbGpPWpGaD
Liotrix—THRA—Gene Expression—HDAC2—chronic obstructive pulmonary disease	0.000109	0.00182	CbGpPWpGaD
Liotrix—ALB—Vitamin B12 Metabolism—SERPINE1—chronic obstructive pulmonary disease	0.000109	0.00182	CbGpPWpGaD
Liotrix—Vomiting—Prednisone—chronic obstructive pulmonary disease	0.000106	0.000409	CcSEcCtD
Liotrix—Rash—Prednisone—chronic obstructive pulmonary disease	0.000105	0.000406	CcSEcCtD
Liotrix—Dermatitis—Prednisone—chronic obstructive pulmonary disease	0.000105	0.000405	CcSEcCtD
Liotrix—Headache—Prednisone—chronic obstructive pulmonary disease	0.000104	0.000403	CcSEcCtD
Liotrix—ABCB1—Allograft Rejection—IL10—chronic obstructive pulmonary disease	0.000104	0.00174	CbGpPWpGaD
Liotrix—CYP2C8—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	0.000101	0.00168	CbGpPWpGaD
Liotrix—SLCO1A2—Metabolism—APIP—chronic obstructive pulmonary disease	9.94e-05	0.00166	CbGpPWpGaD
Liotrix—CYP2C8—Biological oxidations—GCLC—chronic obstructive pulmonary disease	9.94e-05	0.00166	CbGpPWpGaD
Liotrix—ABCB1—Transmembrane transport of small molecules—TRPV4—chronic obstructive pulmonary disease	9.93e-05	0.00166	CbGpPWpGaD
Liotrix—ABCB1—HIF-1-alpha transcription factor network—LEP—chronic obstructive pulmonary disease	9.88e-05	0.00165	CbGpPWpGaD
Liotrix—Nausea—Prednisone—chronic obstructive pulmonary disease	9.88e-05	0.000382	CcSEcCtD
Liotrix—SLC16A10—SLC-mediated transmembrane transport—ALB—chronic obstructive pulmonary disease	9.84e-05	0.00164	CbGpPWpGaD
Liotrix—SLC10A1—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	9.64e-05	0.00161	CbGpPWpGaD
Liotrix—TTR—Extracellular matrix organization—MMP9—chronic obstructive pulmonary disease	9.4e-05	0.00157	CbGpPWpGaD
Liotrix—ABCB1—HIF-1-alpha transcription factor network—NOS2—chronic obstructive pulmonary disease	9.2e-05	0.00154	CbGpPWpGaD
Liotrix—ALB—Selenium Micronutrient Network—CRP—chronic obstructive pulmonary disease	9.15e-05	0.00153	CbGpPWpGaD
Liotrix—ALB—Hemostasis—SERPINE2—chronic obstructive pulmonary disease	9.08e-05	0.00152	CbGpPWpGaD
Liotrix—SLCO1B3—Metabolism of lipids and lipoproteins—CTGF—chronic obstructive pulmonary disease	9.02e-05	0.00151	CbGpPWpGaD
Liotrix—ALB—Folate Metabolism—SERPINE1—chronic obstructive pulmonary disease	8.85e-05	0.00148	CbGpPWpGaD
Liotrix—ALB—Platelet activation, signaling and aggregation—SERPINA1—chronic obstructive pulmonary disease	8.84e-05	0.00148	CbGpPWpGaD
Liotrix—ALB—Vitamin B12 Metabolism—IL1B—chronic obstructive pulmonary disease	8.83e-05	0.00148	CbGpPWpGaD
Liotrix—TTR—Signaling Pathways—PDE4A—chronic obstructive pulmonary disease	8.58e-05	0.00143	CbGpPWpGaD
Liotrix—SLCO1B1—Metabolism—APIP—chronic obstructive pulmonary disease	8.5e-05	0.00142	CbGpPWpGaD
Liotrix—SLCO1B3—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	8.38e-05	0.0014	CbGpPWpGaD
Liotrix—CYP2C8—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	8.35e-05	0.0014	CbGpPWpGaD
Liotrix—SLC16A10—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	8.32e-05	0.00139	CbGpPWpGaD
Liotrix—SLCO1B3—Metabolism of lipids and lipoproteins—CYP1A2—chronic obstructive pulmonary disease	8.31e-05	0.00139	CbGpPWpGaD
Liotrix—CYP2C8—Metapathway biotransformation—CYP1A2—chronic obstructive pulmonary disease	8.24e-05	0.00138	CbGpPWpGaD
Liotrix—SLCO4A1—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	8.22e-05	0.00138	CbGpPWpGaD
Liotrix—SLCO4C1—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	8.22e-05	0.00138	CbGpPWpGaD
Liotrix—SLCO1B3—Metabolism—GC—chronic obstructive pulmonary disease	8.15e-05	0.00136	CbGpPWpGaD
Liotrix—ALB—Hemostasis—RAPGEF3—chronic obstructive pulmonary disease	7.93e-05	0.00133	CbGpPWpGaD
Liotrix—ABCB1—HIF-1-alpha transcription factor network—SERPINE1—chronic obstructive pulmonary disease	7.75e-05	0.0013	CbGpPWpGaD
Liotrix—TTR—Extracellular matrix organization—TGFB1—chronic obstructive pulmonary disease	7.75e-05	0.0013	CbGpPWpGaD
Liotrix—SLCO1B3—SLC-mediated transmembrane transport—ALB—chronic obstructive pulmonary disease	7.68e-05	0.00128	CbGpPWpGaD
Liotrix—ALB—Platelet activation, signaling and aggregation—TGFB2—chronic obstructive pulmonary disease	7.66e-05	0.00128	CbGpPWpGaD
Liotrix—ALB—Platelet degranulation—SERPINE1—chronic obstructive pulmonary disease	7.58e-05	0.00127	CbGpPWpGaD
Liotrix—SLCO1B3—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	7.58e-05	0.00127	CbGpPWpGaD
Liotrix—ALB—Response to elevated platelet cytosolic Ca2+—SERPINE1—chronic obstructive pulmonary disease	7.22e-05	0.00121	CbGpPWpGaD
Liotrix—TTR—Disease—HDAC2—chronic obstructive pulmonary disease	7.22e-05	0.00121	CbGpPWpGaD
Liotrix—ALB—Folate Metabolism—IL1B—chronic obstructive pulmonary disease	7.19e-05	0.0012	CbGpPWpGaD
Liotrix—SLC10A1—Metabolism—GSTT1—chronic obstructive pulmonary disease	7.11e-05	0.00119	CbGpPWpGaD
Liotrix—SLCO1A2—Metabolism of lipids and lipoproteins—CTGF—chronic obstructive pulmonary disease	7.09e-05	0.00119	CbGpPWpGaD
Liotrix—CYP2C8—Metabolism of lipids and lipoproteins—GC—chronic obstructive pulmonary disease	7.07e-05	0.00118	CbGpPWpGaD
Liotrix—SLC10A1—Metabolism—GCLC—chronic obstructive pulmonary disease	7.03e-05	0.00118	CbGpPWpGaD
Liotrix—ALB—Selenium Micronutrient Network—SERPINE1—chronic obstructive pulmonary disease	7.03e-05	0.00118	CbGpPWpGaD
Liotrix—ALB—Metabolism of lipids and lipoproteins—GC—chronic obstructive pulmonary disease	7.03e-05	0.00118	CbGpPWpGaD
Liotrix—CYP2C8—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	6.97e-05	0.00117	CbGpPWpGaD
Liotrix—TTR—Signaling Pathways—CXCR2—chronic obstructive pulmonary disease	6.91e-05	0.00116	CbGpPWpGaD
Liotrix—SLCO1C1—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	6.89e-05	0.00115	CbGpPWpGaD
Liotrix—CYP2C8—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	6.87e-05	0.00115	CbGpPWpGaD
Liotrix—SLC22A8—SLC-mediated transmembrane transport—ALB—chronic obstructive pulmonary disease	6.8e-05	0.00114	CbGpPWpGaD
Liotrix—TTR—Disease—KL—chronic obstructive pulmonary disease	6.71e-05	0.00112	CbGpPWpGaD
Liotrix—SLCO1A2—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	6.58e-05	0.0011	CbGpPWpGaD
Liotrix—SLC10A1—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	6.55e-05	0.0011	CbGpPWpGaD
Liotrix—SLCO1A2—Metabolism of lipids and lipoproteins—CYP1A2—chronic obstructive pulmonary disease	6.53e-05	0.00109	CbGpPWpGaD
Liotrix—SLCO1B3—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	6.5e-05	0.00109	CbGpPWpGaD
Liotrix—SLC10A1—Metabolism—CTGF—chronic obstructive pulmonary disease	6.41e-05	0.00107	CbGpPWpGaD
Liotrix—ALB—Vitamin B12 Metabolism—TNF—chronic obstructive pulmonary disease	6.41e-05	0.00107	CbGpPWpGaD
Liotrix—SLCO1A2—Metabolism—GC—chronic obstructive pulmonary disease	6.4e-05	0.00107	CbGpPWpGaD
Liotrix—CYP2C8—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	6.4e-05	0.00107	CbGpPWpGaD
Liotrix—CYP2C8—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	6.32e-05	0.00106	CbGpPWpGaD
Liotrix—CYP2C8—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	6.07e-05	0.00102	CbGpPWpGaD
Liotrix—SLCO1B1—Metabolism of lipids and lipoproteins—CTGF—chronic obstructive pulmonary disease	6.06e-05	0.00101	CbGpPWpGaD
Liotrix—SLCO1B3—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	6.04e-05	0.00101	CbGpPWpGaD
Liotrix—SLCO1A2—SLC-mediated transmembrane transport—ALB—chronic obstructive pulmonary disease	6.03e-05	0.00101	CbGpPWpGaD
Liotrix—CYP2C8—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	5.99e-05	0.001	CbGpPWpGaD
Liotrix—SLCO1A2—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	5.95e-05	0.000996	CbGpPWpGaD
Liotrix—SLC10A1—Metabolism—CYP1A2—chronic obstructive pulmonary disease	5.91e-05	0.000988	CbGpPWpGaD
Liotrix—SLC22A8—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	5.75e-05	0.000962	CbGpPWpGaD
Liotrix—ALB—Selenium Micronutrient Network—IL1B—chronic obstructive pulmonary disease	5.71e-05	0.000955	CbGpPWpGaD
Liotrix—ABCB1—Allograft Rejection—CXCL8—chronic obstructive pulmonary disease	5.68e-05	0.000951	CbGpPWpGaD
Liotrix—SLCO1B1—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	5.63e-05	0.000942	CbGpPWpGaD
Liotrix—SLCO1B1—Metabolism of lipids and lipoproteins—CYP1A2—chronic obstructive pulmonary disease	5.58e-05	0.000934	CbGpPWpGaD
Liotrix—SLCO1B1—Metabolism—GC—chronic obstructive pulmonary disease	5.48e-05	0.000916	CbGpPWpGaD
Liotrix—ABCB1—Allograft Rejection—IL1B—chronic obstructive pulmonary disease	5.45e-05	0.000912	CbGpPWpGaD
Liotrix—THRA—Gene Expression—SERPINE1—chronic obstructive pulmonary disease	5.34e-05	0.000893	CbGpPWpGaD
Liotrix—THRB—Gene Expression—SERPINE1—chronic obstructive pulmonary disease	5.34e-05	0.000893	CbGpPWpGaD
Liotrix—ABCB1—HIF-1-alpha transcription factor network—VEGFA—chronic obstructive pulmonary disease	5.33e-05	0.000892	CbGpPWpGaD
Liotrix—ALB—Platelet degranulation—VEGFA—chronic obstructive pulmonary disease	5.22e-05	0.000872	CbGpPWpGaD
Liotrix—ALB—Folate Metabolism—TNF—chronic obstructive pulmonary disease	5.21e-05	0.000872	CbGpPWpGaD
Liotrix—ALB—Vitamin B12 Metabolism—IL6—chronic obstructive pulmonary disease	5.17e-05	0.000865	CbGpPWpGaD
Liotrix—SLCO1B1—SLC-mediated transmembrane transport—ALB—chronic obstructive pulmonary disease	5.16e-05	0.000863	CbGpPWpGaD
Liotrix—SLCO1A2—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	5.11e-05	0.000854	CbGpPWpGaD
Liotrix—SLCO1B1—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	5.09e-05	0.000852	CbGpPWpGaD
Liotrix—TTR—Signaling Pathways—HDAC2—chronic obstructive pulmonary disease	5.05e-05	0.000845	CbGpPWpGaD
Liotrix—TTR—Disease—ERBB3—chronic obstructive pulmonary disease	5.03e-05	0.000841	CbGpPWpGaD
Liotrix—SLC16A10—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	5e-05	0.000836	CbGpPWpGaD
Liotrix—ALB—Response to elevated platelet cytosolic Ca2+—VEGFA—chronic obstructive pulmonary disease	4.97e-05	0.000831	CbGpPWpGaD
Liotrix—SLC10A1—Metabolism—GSTP1—chronic obstructive pulmonary disease	4.93e-05	0.000824	CbGpPWpGaD
Liotrix—CYP2C8—Metabolism—APIP—chronic obstructive pulmonary disease	4.88e-05	0.000817	CbGpPWpGaD
Liotrix—SLC10A1—Metabolism—HMOX1—chronic obstructive pulmonary disease	4.86e-05	0.000813	CbGpPWpGaD
Liotrix—ALB—Metabolism—APIP—chronic obstructive pulmonary disease	4.86e-05	0.000812	CbGpPWpGaD
Liotrix—ALB—Platelet degranulation—TGFB1—chronic obstructive pulmonary disease	4.79e-05	0.000801	CbGpPWpGaD
Liotrix—SLCO1A2—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	4.74e-05	0.000793	CbGpPWpGaD
Liotrix—TTR—Signaling Pathways—KL—chronic obstructive pulmonary disease	4.7e-05	0.000786	CbGpPWpGaD
Liotrix—ABCB1—Allograft Rejection—VEGFA—chronic obstructive pulmonary disease	4.62e-05	0.000772	CbGpPWpGaD
Liotrix—ALB—Folate Metabolism—TP53—chronic obstructive pulmonary disease	4.6e-05	0.000769	CbGpPWpGaD
Liotrix—ALB—Response to elevated platelet cytosolic Ca2+—TGFB1—chronic obstructive pulmonary disease	4.56e-05	0.000763	CbGpPWpGaD
Liotrix—ALB—Hemostasis—SERPINA1—chronic obstructive pulmonary disease	4.56e-05	0.000762	CbGpPWpGaD
Liotrix—SLC10A1—Metabolism—GSTM1—chronic obstructive pulmonary disease	4.53e-05	0.000758	CbGpPWpGaD
Liotrix—SLCO1B3—Metabolism—GSTT1—chronic obstructive pulmonary disease	4.45e-05	0.000745	CbGpPWpGaD
Liotrix—SLCO1B3—Metabolism—GCLC—chronic obstructive pulmonary disease	4.4e-05	0.000736	CbGpPWpGaD
Liotrix—SLCO1B1—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	4.37e-05	0.00073	CbGpPWpGaD
Liotrix—TTR—Signaling Pathways—ADRB2—chronic obstructive pulmonary disease	4.34e-05	0.000725	CbGpPWpGaD
Liotrix—SLC10A1—Metabolism—CYP1A1—chronic obstructive pulmonary disease	4.29e-05	0.000718	CbGpPWpGaD
Liotrix—ABCB1—Metabolism—APIP—chronic obstructive pulmonary disease	4.25e-05	0.000712	CbGpPWpGaD
Liotrix—ABCB1—Allograft Rejection—TGFB1—chronic obstructive pulmonary disease	4.24e-05	0.000709	CbGpPWpGaD
Liotrix—ALB—Folate Metabolism—IL6—chronic obstructive pulmonary disease	4.21e-05	0.000704	CbGpPWpGaD
Liotrix—TTR—Disease—NOS2—chronic obstructive pulmonary disease	4.19e-05	0.000701	CbGpPWpGaD
Liotrix—ALB—Selenium Micronutrient Network—TNF—chronic obstructive pulmonary disease	4.14e-05	0.000693	CbGpPWpGaD
Liotrix—SLCO1B3—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	4.1e-05	0.000686	CbGpPWpGaD
Liotrix—SLCO1B1—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	4.06e-05	0.000678	CbGpPWpGaD
Liotrix—SLCO1B3—Metabolism—CTGF—chronic obstructive pulmonary disease	4.02e-05	0.000672	CbGpPWpGaD
Liotrix—ABCB1—Allograft Rejection—TNF—chronic obstructive pulmonary disease	3.96e-05	0.000662	CbGpPWpGaD
Liotrix—ALB—Hemostasis—TGFB2—chronic obstructive pulmonary disease	3.95e-05	0.000661	CbGpPWpGaD
Liotrix—SLCO1B3—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	3.9e-05	0.000653	CbGpPWpGaD
Liotrix—TTR—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	3.87e-05	0.000648	CbGpPWpGaD
Liotrix—SLCO1B3—Metabolism—CYP1A2—chronic obstructive pulmonary disease	3.7e-05	0.000619	CbGpPWpGaD
Liotrix—ALB—Hemostasis—HDAC2—chronic obstructive pulmonary disease	3.54e-05	0.000593	CbGpPWpGaD
Liotrix—TTR—Disease—SERPINE1—chronic obstructive pulmonary disease	3.53e-05	0.000591	CbGpPWpGaD
Liotrix—TTR—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	3.52e-05	0.000589	CbGpPWpGaD
Liotrix—SLCO1A2—Metabolism—GSTT1—chronic obstructive pulmonary disease	3.5e-05	0.000585	CbGpPWpGaD
Liotrix—CYP2C8—Metabolism of lipids and lipoproteins—CTGF—chronic obstructive pulmonary disease	3.48e-05	0.000582	CbGpPWpGaD
Liotrix—ALB—Metabolism of lipids and lipoproteins—CTGF—chronic obstructive pulmonary disease	3.46e-05	0.000579	CbGpPWpGaD
Liotrix—SLCO1A2—Metabolism—GCLC—chronic obstructive pulmonary disease	3.46e-05	0.000578	CbGpPWpGaD
Liotrix—SLC22A8—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	3.45e-05	0.000578	CbGpPWpGaD
Liotrix—TTR—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	3.39e-05	0.000567	CbGpPWpGaD
Liotrix—TTR—Disease—NOS3—chronic obstructive pulmonary disease	3.37e-05	0.000564	CbGpPWpGaD
Liotrix—ALB—Platelet activation, signaling and aggregation—SERPINE1—chronic obstructive pulmonary disease	3.36e-05	0.000563	CbGpPWpGaD
Liotrix—ALB—Selenium Micronutrient Network—IL6—chronic obstructive pulmonary disease	3.34e-05	0.000559	CbGpPWpGaD
Liotrix—CYP2C8—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	3.24e-05	0.000541	CbGpPWpGaD
Liotrix—SLCO1A2—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	3.22e-05	0.000539	CbGpPWpGaD
Liotrix—ALB—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	3.22e-05	0.000538	CbGpPWpGaD
Liotrix—CYP2C8—Metabolism of lipids and lipoproteins—CYP1A2—chronic obstructive pulmonary disease	3.21e-05	0.000537	CbGpPWpGaD
Liotrix—ALB—Hemostasis—PLAUR—chronic obstructive pulmonary disease	3.2e-05	0.000534	CbGpPWpGaD
Liotrix—ALB—Metabolism of lipids and lipoproteins—CYP1A2—chronic obstructive pulmonary disease	3.19e-05	0.000534	CbGpPWpGaD
Liotrix—SLCO1A2—Metabolism—CTGF—chronic obstructive pulmonary disease	3.16e-05	0.000528	CbGpPWpGaD
Liotrix—TTR—Signaling Pathways—LEP—chronic obstructive pulmonary disease	3.15e-05	0.000527	CbGpPWpGaD
Liotrix—CYP2C8—Metabolism—GC—chronic obstructive pulmonary disease	3.15e-05	0.000526	CbGpPWpGaD
Liotrix—ALB—Metabolism—GC—chronic obstructive pulmonary disease	3.13e-05	0.000523	CbGpPWpGaD
Liotrix—SLCO1B3—Metabolism—GSTP1—chronic obstructive pulmonary disease	3.09e-05	0.000516	CbGpPWpGaD
Liotrix—SLCO1A2—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	3.07e-05	0.000513	CbGpPWpGaD
Liotrix—SLCO1B3—Metabolism—HMOX1—chronic obstructive pulmonary disease	3.04e-05	0.000509	CbGpPWpGaD
Liotrix—SLCO1B1—Metabolism—GSTT1—chronic obstructive pulmonary disease	2.99e-05	0.0005	CbGpPWpGaD
Liotrix—SLCO1B1—Metabolism—GCLC—chronic obstructive pulmonary disease	2.96e-05	0.000495	CbGpPWpGaD
Liotrix—CYP2C8—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	2.93e-05	0.000489	CbGpPWpGaD
Liotrix—SLC10A1—Metabolism—ALB—chronic obstructive pulmonary disease	2.92e-05	0.000488	CbGpPWpGaD
Liotrix—ALB—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	2.91e-05	0.000487	CbGpPWpGaD
Liotrix—SLCO1A2—Metabolism—CYP1A2—chronic obstructive pulmonary disease	2.91e-05	0.000486	CbGpPWpGaD
Liotrix—SLCO1B3—Metabolism—GSTM1—chronic obstructive pulmonary disease	2.84e-05	0.000474	CbGpPWpGaD
Liotrix—ABCB1—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	2.82e-05	0.000471	CbGpPWpGaD
Liotrix—SLC10A1—Metabolism—NOS3—chronic obstructive pulmonary disease	2.79e-05	0.000467	CbGpPWpGaD
Liotrix—SLCO1B1—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	2.76e-05	0.000461	CbGpPWpGaD
Liotrix—ABCB1—Metabolism—GC—chronic obstructive pulmonary disease	2.74e-05	0.000459	CbGpPWpGaD
Liotrix—SLCO1B1—Metabolism—CTGF—chronic obstructive pulmonary disease	2.7e-05	0.000451	CbGpPWpGaD
Liotrix—SLCO1B3—Metabolism—CYP1A1—chronic obstructive pulmonary disease	2.69e-05	0.00045	CbGpPWpGaD
Liotrix—SLCO1B1—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	2.62e-05	0.000439	CbGpPWpGaD
Liotrix—ABCB1—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	2.55e-05	0.000426	CbGpPWpGaD
Liotrix—ALB—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	2.49e-05	0.000417	CbGpPWpGaD
Liotrix—SLCO1B1—Metabolism—CYP1A2—chronic obstructive pulmonary disease	2.49e-05	0.000416	CbGpPWpGaD
Liotrix—TTR—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	2.47e-05	0.000414	CbGpPWpGaD
Liotrix—SLCO1A2—Metabolism—GSTP1—chronic obstructive pulmonary disease	2.43e-05	0.000406	CbGpPWpGaD
Liotrix—SLCO1A2—Metabolism—HMOX1—chronic obstructive pulmonary disease	2.39e-05	0.0004	CbGpPWpGaD
Liotrix—TTR—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	2.36e-05	0.000395	CbGpPWpGaD
Liotrix—CYP2C8—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	2.33e-05	0.00039	CbGpPWpGaD
Liotrix—ALB—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	2.32e-05	0.000388	CbGpPWpGaD
Liotrix—ALB—Platelet activation, signaling and aggregation—VEGFA—chronic obstructive pulmonary disease	2.31e-05	0.000387	CbGpPWpGaD
Liotrix—ALB—Hemostasis—MMP1—chronic obstructive pulmonary disease	2.28e-05	0.000382	CbGpPWpGaD
Liotrix—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—chronic obstructive pulmonary disease	2.28e-05	0.000381	CbGpPWpGaD
Liotrix—ALB—Hemostasis—PLAU—chronic obstructive pulmonary disease	2.24e-05	0.000375	CbGpPWpGaD
Liotrix—TTR—Disease—TGFB1—chronic obstructive pulmonary disease	2.23e-05	0.000373	CbGpPWpGaD
Liotrix—SLCO1A2—Metabolism—GSTM1—chronic obstructive pulmonary disease	2.23e-05	0.000373	CbGpPWpGaD
Liotrix—ABCB1—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	2.19e-05	0.000366	CbGpPWpGaD
Liotrix—TTR—Disease—EGFR—chronic obstructive pulmonary disease	2.19e-05	0.000366	CbGpPWpGaD
Liotrix—ALB—Platelet activation, signaling and aggregation—TGFB1—chronic obstructive pulmonary disease	2.12e-05	0.000355	CbGpPWpGaD
Liotrix—SLCO1A2—Metabolism—CYP1A1—chronic obstructive pulmonary disease	2.11e-05	0.000353	CbGpPWpGaD
Liotrix—TTR—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	2.09e-05	0.00035	CbGpPWpGaD
Liotrix—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—chronic obstructive pulmonary disease	2.09e-05	0.00035	CbGpPWpGaD
Liotrix—SLCO1B1—Metabolism—GSTP1—chronic obstructive pulmonary disease	2.07e-05	0.000347	CbGpPWpGaD
Liotrix—ALB—Hemostasis—NOS2—chronic obstructive pulmonary disease	2.06e-05	0.000344	CbGpPWpGaD
Liotrix—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—chronic obstructive pulmonary disease	2.05e-05	0.000343	CbGpPWpGaD
Liotrix—SLCO1B1—Metabolism—HMOX1—chronic obstructive pulmonary disease	2.05e-05	0.000342	CbGpPWpGaD
Liotrix—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—chronic obstructive pulmonary disease	1.95e-05	0.000327	CbGpPWpGaD
Liotrix—SLCO1B1—Metabolism—GSTM1—chronic obstructive pulmonary disease	1.91e-05	0.000319	CbGpPWpGaD
Liotrix—TTR—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	1.89e-05	0.000317	CbGpPWpGaD
Liotrix—SLCO1B3—Metabolism—ALB—chronic obstructive pulmonary disease	1.83e-05	0.000306	CbGpPWpGaD
Liotrix—SLCO1B1—Metabolism—CYP1A1—chronic obstructive pulmonary disease	1.81e-05	0.000302	CbGpPWpGaD
Liotrix—SLCO1B3—Metabolism—NOS3—chronic obstructive pulmonary disease	1.75e-05	0.000292	CbGpPWpGaD
Liotrix—ALB—Hemostasis—SERPINE1—chronic obstructive pulmonary disease	1.73e-05	0.00029	CbGpPWpGaD
Liotrix—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—chronic obstructive pulmonary disease	1.72e-05	0.000288	CbGpPWpGaD
Liotrix—CYP2C8—Metabolism—GSTT1—chronic obstructive pulmonary disease	1.72e-05	0.000288	CbGpPWpGaD
Liotrix—ALB—Metabolism—GSTT1—chronic obstructive pulmonary disease	1.71e-05	0.000286	CbGpPWpGaD
Liotrix—TTR—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	1.7e-05	0.000284	CbGpPWpGaD
Liotrix—CYP2C8—Metabolism—GCLC—chronic obstructive pulmonary disease	1.7e-05	0.000284	CbGpPWpGaD
Liotrix—ALB—Metabolism—GCLC—chronic obstructive pulmonary disease	1.69e-05	0.000283	CbGpPWpGaD
Liotrix—TTR—Disease—IL6—chronic obstructive pulmonary disease	1.68e-05	0.000281	CbGpPWpGaD
Liotrix—ALB—Hemostasis—NOS3—chronic obstructive pulmonary disease	1.66e-05	0.000277	CbGpPWpGaD
Liotrix—CYP2C8—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	1.58e-05	0.000265	CbGpPWpGaD
Liotrix—TTR—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	1.56e-05	0.000261	CbGpPWpGaD
Liotrix—CYP2C8—Metabolism—CTGF—chronic obstructive pulmonary disease	1.55e-05	0.000259	CbGpPWpGaD
Liotrix—ALB—Metabolism—CTGF—chronic obstructive pulmonary disease	1.54e-05	0.000258	CbGpPWpGaD
Liotrix—TTR—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	1.53e-05	0.000256	CbGpPWpGaD
Liotrix—ABCB1—Metabolism—GSTT1—chronic obstructive pulmonary disease	1.5e-05	0.000251	CbGpPWpGaD
Liotrix—ABCB1—Metabolism—GCLC—chronic obstructive pulmonary disease	1.48e-05	0.000248	CbGpPWpGaD
Liotrix—SLCO1A2—Metabolism—ALB—chronic obstructive pulmonary disease	1.44e-05	0.00024	CbGpPWpGaD
Liotrix—CYP2C8—Metabolism—CYP1A2—chronic obstructive pulmonary disease	1.43e-05	0.000239	CbGpPWpGaD
Liotrix—ALB—Metabolism—CYP1A2—chronic obstructive pulmonary disease	1.42e-05	0.000238	CbGpPWpGaD
Liotrix—SLCO1A2—Metabolism—NOS3—chronic obstructive pulmonary disease	1.37e-05	0.00023	CbGpPWpGaD
Liotrix—ABCB1—Metabolism—CTGF—chronic obstructive pulmonary disease	1.35e-05	0.000226	CbGpPWpGaD
Liotrix—ABCB1—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	1.31e-05	0.00022	CbGpPWpGaD
Liotrix—TTR—Signaling Pathways—TP53—chronic obstructive pulmonary disease	1.29e-05	0.000215	CbGpPWpGaD
Liotrix—ABCB1—Metabolism—CYP1A2—chronic obstructive pulmonary disease	1.24e-05	0.000208	CbGpPWpGaD
Liotrix—SLCO1B1—Metabolism—ALB—chronic obstructive pulmonary disease	1.23e-05	0.000205	CbGpPWpGaD
Liotrix—ALB—Hemostasis—VEGFA—chronic obstructive pulmonary disease	1.19e-05	0.000199	CbGpPWpGaD
Liotrix—CYP2C8—Metabolism—GSTP1—chronic obstructive pulmonary disease	1.19e-05	0.000199	CbGpPWpGaD
Liotrix—ALB—Metabolism—GSTP1—chronic obstructive pulmonary disease	1.18e-05	0.000198	CbGpPWpGaD
Liotrix—TTR—Signaling Pathways—IL6—chronic obstructive pulmonary disease	1.18e-05	0.000197	CbGpPWpGaD
Liotrix—CYP2C8—Metabolism—HMOX1—chronic obstructive pulmonary disease	1.18e-05	0.000197	CbGpPWpGaD
Liotrix—SLCO1B1—Metabolism—NOS3—chronic obstructive pulmonary disease	1.17e-05	0.000196	CbGpPWpGaD
Liotrix—ALB—Metabolism—HMOX1—chronic obstructive pulmonary disease	1.17e-05	0.000195	CbGpPWpGaD
Liotrix—CYP2C8—Metabolism—GSTM1—chronic obstructive pulmonary disease	1.1e-05	0.000183	CbGpPWpGaD
Liotrix—ALB—Hemostasis—TGFB1—chronic obstructive pulmonary disease	1.09e-05	0.000183	CbGpPWpGaD
Liotrix—ALB—Metabolism—GSTM1—chronic obstructive pulmonary disease	1.09e-05	0.000182	CbGpPWpGaD
Liotrix—ABCB1—Metabolism—GSTP1—chronic obstructive pulmonary disease	1.04e-05	0.000174	CbGpPWpGaD
Liotrix—CYP2C8—Metabolism—CYP1A1—chronic obstructive pulmonary disease	1.04e-05	0.000174	CbGpPWpGaD
Liotrix—ALB—Metabolism—CYP1A1—chronic obstructive pulmonary disease	1.03e-05	0.000173	CbGpPWpGaD
Liotrix—ABCB1—Metabolism—HMOX1—chronic obstructive pulmonary disease	1.02e-05	0.000171	CbGpPWpGaD
Liotrix—ABCB1—Metabolism—GSTM1—chronic obstructive pulmonary disease	9.54e-06	0.00016	CbGpPWpGaD
Liotrix—ABCB1—Metabolism—CYP1A1—chronic obstructive pulmonary disease	9.04e-06	0.000151	CbGpPWpGaD
Liotrix—ALB—Hemostasis—TP53—chronic obstructive pulmonary disease	9.01e-06	0.000151	CbGpPWpGaD
Liotrix—CYP2C8—Metabolism—ALB—chronic obstructive pulmonary disease	7.06e-06	0.000118	CbGpPWpGaD
Liotrix—CYP2C8—Metabolism—NOS3—chronic obstructive pulmonary disease	6.75e-06	0.000113	CbGpPWpGaD
Liotrix—ALB—Metabolism—NOS3—chronic obstructive pulmonary disease	6.71e-06	0.000112	CbGpPWpGaD
Liotrix—ABCB1—Metabolism—ALB—chronic obstructive pulmonary disease	6.15e-06	0.000103	CbGpPWpGaD
Liotrix—ABCB1—Metabolism—NOS3—chronic obstructive pulmonary disease	5.88e-06	9.84e-05	CbGpPWpGaD
